Background Image
Table of Contents Table of Contents
Previous Page  1259 / 1266 Next Page
Information
Show Menu
Previous Page 1259 / 1266 Next Page
Page Background

Dexamethasone dosing

• 96 patients; 2 randomized, double-blind trials

• Dexamethasone:

4 vs. 16 mg/d

8 vs. 16 mg/d

Primary endpoint: KPS => no difference

• Side effects: more frequent in patients taking 16 mg/d

Vecht et al., Neurology 1994